Cargando…

Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma

BACKGROUND: Sebaceous carcinoma is an aggressive adnexal skin tumor with a predilection for the eyelids and sebaceous glands of the head and neck. CASE PRESENTATION: A 73 year-old man presented with confusion and was found to have widely disseminated sebaceous carcinoma with metastases to brain, lun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domingo-Musibay, Evidio, Murugan, Paari, Giubellino, Alessio, Sharma, Sandeep, Steinberger, Daniel, Yuan, Jianling, Hunt, Matthew A., Lou, Emil, Miller, Jeffrey S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006706/ https://www.ncbi.nlm.nih.gov/pubmed/29914578 http://dx.doi.org/10.1186/s40425-018-0357-3

Ejemplares similares

Combination treatment of bilateral periocular sebaceous carcinomas with microsatellite instability with neoadjuvant pembrolizumab and Mohs surgery
por: Woods, Alexander D., et al.
Publicado: (2022)

Gene Expression and Mutational Profile in BAP-1 Inactivated Melanocytic Lesions of Progressive Malignancy from a Patient with Multiple Lesions
por: Zhou, Yan, et al.
Publicado: (2021)

Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncology Patients
por: Özütemiz, Can, et al.
Publicado: (2021)

Prospective Trial of Monocyte Count as a Biomarker of Hand-Foot Syndrome Among Patients With Soft Tissue Sarcomas Treated With Pegylated Liposomal Doxorubicin and Ifosfamide
por: Skubitz, Keith M, et al.
Publicado: (2022)

Prospective Trial of Neutrophil/Lymphocyte Ratio and Other Blood Counts as Biomarkers of Survival among Patients with High-Grade Soft Tissue Sarcomas Treated with Pegylated Liposomal Doxorubicin and Ifosfamide
por: Skubitz, Keith M., et al.
Publicado: (2022)

Pembrolizumab for a patient with metastatic castration‐resistant prostate cancer with microsatellite instability‐high
por: Fujiwara, Motohiro, et al.
Publicado: (2020)

Primary lung sebaceous carcinoma successfully treated with radiotherapy and pembrolizumab: A case report
por: Jodai, Yasumiko, et al.
Publicado: (2022)

Regorafenib and Nivolumab or Pembrolizumab Combination and Circulating Tumor DNA Response Assessment in Refractory Microsatellite Stable Colorectal Cancer
por: Wang, Chongkai, et al.
Publicado: (2020)

Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer?
por: Ghiringhelli, François, et al.
Publicado: (2019)

A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer
por: Garralda, E., et al.
Publicado: (2022)

A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancer
por: Baretti, Marina, et al.
Publicado: (2023)

Endogenous Heat‐Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma
por: Domingo‐Musibay, Evidio, et al.
Publicado: (2017)

Plasmacytoid Urothelial Carcinoma of the Bladder Metastatic to the Stomach: A Case Report
por: Nabbout, Philippe, et al.
Publicado: (2012)

Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer
por: Pecci, Federica, et al.
Publicado: (2021)

Sebaceous Carcinoma Arising from the Nevus Sebaceous
por: Jo, Myoung-Soo, et al.
Publicado: (2012)

Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA
por: Barata, Pedro, et al.
Publicado: (2020)

A Patient with Metastatic Microsatellite Instability-High Pancreatic Ductal Adenocarcinoma with a Prolonged Response to Single-Agent Pembrolizumab
por: Guedikian, Annie A., et al.
Publicado: (2021)

Measles Edmonston Vaccine Strain Derivatives have Potent Oncolytic Activity against Osteosarcoma
por: Musibay, Evidio Domingo, et al.
Publicado: (2014)

Durable response to pembrolizumab in microsatellite instability‐high advanced adrenocortical carcinoma
por: Senda, Masaya, et al.
Publicado: (2023)

Dermoscopic clues for sebaceous carcinoma arising in nevus sebaceous
por: Pradhan, Sushmita, et al.
Publicado: (2020)

Synthesis and Characterization of Curcumin-Loaded Nanoparticles of Poly(Glycerol Sebacate): A Novel Highly Stable Anticancer System
por: Massironi, Alessio, et al.
Publicado: (2022)

Widespread sebaceous neoplasms in the setting of chronic immunosuppression with near-complete clearance on isotretinoin
por: El-Behaedi, Salma, et al.
Publicado: (2022)

The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives
por: Gandini, Annalice, et al.
Publicado: (2023)

Sebaceous Horn
por: Murison, C. C.
Publicado: (1921)

Sebaceous Tumors
Publicado: (1877)

Sebaceous Filaments
por: Singh, Yuvrah, et al.
Publicado: (2021)

Sebaceous Neoplasms
por: Papadimitriou, Ilias, et al.
Publicado: (2023)

Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report
por: Yoshida, Tsukasa, et al.
Publicado: (2022)

Metastatic Malignant Perivascular Epithelioid Cell Tumors With Microsatellite Instability Within Lynch Syndrome Successfully Treated With Anti-PD1 Pembrolizumab
por: Djerroudi, Lounes, et al.
Publicado: (2023)

Metastatic Hepatocellular Carcinoma Responsive to Pembrolizumab
por: Truong, Phu, et al.
Publicado: (2016)

Metastatic Porocarcinoma Effectively Managed by Pembrolizumab
por: Singh, Arminder, et al.
Publicado: (2021)

Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma
por: San-Román-Gil, María, et al.
Publicado: (2023)

Poroma with Sebaceous Differentiation: Dermoscopy for the Diagnosis of Skin Tumor with Sebaceous Differentiation
por: Ito, Takamichi, et al.
Publicado: (2015)

The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer
por: Trullas, A., et al.
Publicado: (2021)

Primary or metastatic lung cancer? Sebaceous carcinoma of the thigh: A case report
por: Wei, Xiao-Lin, et al.
Publicado: (2022)

Complete Response to Pembrolizumab in Advanced Colon Cancer Harboring Somatic POLE F367S Mutation with Microsatellite Stability Status: A Case Study
por: Chen, Jianxin, et al.
Publicado: (2021)

Successful pembrolizumab treatment of microsatellite instability‐high intrahepatic cholangiocarcinoma: A case report
por: Ikeda, Yuki, et al.
Publicado: (2021)

Success rate of microsatellite instability examination and complete response with pembrolizumab in biliary tract cancer
por: Kai, Yugo, et al.
Publicado: (2021)

Pembrolizumab in Asian patients with microsatellite‐instability‐high/mismatch‐repair‐deficient colorectal cancer
por: Yoshino, Takayuki, et al.
Publicado: (2022)

Sebaceous glands in the esophagus.
por: Bae, J. Y., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_p0g134u3l1i7hgusvv16qlc2ha